Drugmakers Likely To Push Back Against FDA’s Pharma Ad Rules

The White House’s crackdown on one of radio’s top revenue drivers is entering a new phase, but regulatory experts warn drugmakers won’t stay quiet as FDA scrutiny on pharmaceutical ads ramps up, raising questions about the vertical’s future.